By Peter Nurse
Investing.com -- Stocks in focus in premarket trade on Tuesday, September 6th. Please refresh for updates.
CVS Health (NYSE:CVS) stock rose 1.5% after agreeing to buy home healthcare services company Signify Health (NYSE:SGFY), down 0.1%, for about $8 billion in cash, a move that will enable one of the largest U.S. healthcare companies to provide further care management to patients in their homes.
Bed Bath & Beyond (NASDAQ:BBBY) stock slumped 15.1% after the suicide of the troubled retailer’s chief financial officer on Friday, days after it announced it was closing stores and laying off workers.
Illumina (NASDAQ:ILMN) stock rose 4% after the European Union blocked the biotech company's $7.1 billion acquisition of cancer detection test maker Grail on antitrust grounds.
Tesla (NASDAQ:TSLA) stock rose 0.9% after Wolfe Research upgraded its investment stance on the electric car manufacturer to ‘outperform’ from ‘peer perform’, saying it can rise 30%, benefitting from the Inflation Reduction Act.
Brigham Minerals (NYSE:MNRL) stock fell 3.1% after the Wall Street Journal reported that it was set to merge with Sitio Royalties (NASDAQ:STR), down 1.7%, in one of the largest deals in the oil-and-gas industry this year.
Anheuser Busch Inbev (NYSE:BUD) ADRs rose 2.4% after HSBC upgraded its stance on the brewer to ‘buy’ from ‘hold’, saying the stock can surge 30% on the strength of its premium brands.
Digital World Acquisition Corp (NASDAQ:DWAC) stock tumbled 21% after Reuters reported the blank-check acquisition firm that agreed to merge with Donald Trump's social media company failed to secure enough shareholder support for an extension to complete the deal.